Anti‐tumour actions of cannabinoids

@article{Hinz2019AntitumourAO,
  title={Anti‐tumour actions of cannabinoids},
  author={B. Hinz and R. Ramer},
  journal={British Journal of Pharmacology},
  year={2019},
  volume={176},
  pages={1384 - 1394}
}
The endocannabinoid system has emerged as an important target for the treatment of many diverse diseases. In addition to the well‐established palliative effects of cannabinoids in cancer therapy, phytocannabinoids, synthetic cannabinoid compounds and inhibitors of endocannabinoid degradation have attracted attention as possible systemic anticancer drugs. Results emerging from preclinical studies suggest cannabinoids elicit effects at different levels of cancer progression, including inhibition… Expand
Antitumor Cannabinoid Chemotypes: Structural Insights
Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
The Endocannabinoid System: A Target for Cancer Treatment
Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.
A Guide to Targeting the Endocannabinoid System in Drug Design
The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 125 REFERENCES
Cannabinoids as Anticancer Drugs.
Antitumorigenic targets of cannabinoids – current status and implications
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Cannabidiol inhibits angiogenesis by multiple mechanisms
Cannabinoids: a new hope for breast cancer therapy?
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
Inhibition of tumor angiogenesis by cannabinoids
Cannabinoid receptors as novel targets for the treatment of melanoma
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
...
1
2
3
4
5
...